KR20120079983A - Novel gallotannin compound isolated from leaf of acer ginnala and antioxidative composition comprising the same as acitive ingredient - Google Patents
Novel gallotannin compound isolated from leaf of acer ginnala and antioxidative composition comprising the same as acitive ingredient Download PDFInfo
- Publication number
- KR20120079983A KR20120079983A KR1020110001375A KR20110001375A KR20120079983A KR 20120079983 A KR20120079983 A KR 20120079983A KR 1020110001375 A KR1020110001375 A KR 1020110001375A KR 20110001375 A KR20110001375 A KR 20110001375A KR 20120079983 A KR20120079983 A KR 20120079983A
- Authority
- KR
- South Korea
- Prior art keywords
- novel
- composition
- compound
- present
- gallotannin
- Prior art date
Links
- -1 gallotannin compound Chemical class 0.000 title claims abstract description 41
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 229920002824 gallotannin Polymers 0.000 title claims abstract description 31
- 230000003078 antioxidant effect Effects 0.000 title claims description 26
- 235000015988 Acer ginnala Nutrition 0.000 title abstract description 7
- 241000580956 Acer tataricum subsp. ginnala Species 0.000 title abstract 2
- 239000004615 ingredient Substances 0.000 title description 4
- 239000004480 active ingredient Substances 0.000 claims abstract description 10
- 239000002537 cosmetic Substances 0.000 claims abstract description 10
- 235000013376 functional food Nutrition 0.000 claims abstract description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 19
- 150000001875 compounds Chemical class 0.000 abstract description 25
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 abstract description 20
- MAAFPSYEXHLRIU-LTCOOKNTSA-N [(3s,4r,5s,6r)-4-hydroxy-6-(hydroxymethyl)-5-(3,4,5-trihydroxybenzoyl)oxyoxan-3-yl] 3,4,5-trihydroxybenzoate Chemical compound O([C@H]1CO[C@@H]([C@H]([C@@H]1O)OC(=O)C=1C=C(O)C(O)=C(O)C=1)CO)C(=O)C1=CC(O)=C(O)C(O)=C1 MAAFPSYEXHLRIU-LTCOOKNTSA-N 0.000 abstract description 14
- 239000006071 cream Substances 0.000 abstract description 7
- 239000000843 powder Substances 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 7
- 239000006210 lotion Substances 0.000 abstract description 6
- 239000000839 emulsion Substances 0.000 abstract description 5
- 239000000499 gel Substances 0.000 abstract description 5
- 239000007921 spray Substances 0.000 abstract description 5
- 239000006072 paste Substances 0.000 abstract description 3
- 239000000725 suspension Substances 0.000 abstract description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 abstract description 2
- 239000000344 soap Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 abstract description 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract 3
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 230000002292 Radical scavenging effect Effects 0.000 description 30
- 239000000284 extract Substances 0.000 description 19
- 235000006708 antioxidants Nutrition 0.000 description 16
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 229960002920 sorbitol Drugs 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- 244000102051 Acer ginnala Species 0.000 description 5
- LRFVTYWOQMYALW-UHFFFAOYSA-N Xanthine Natural products O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 5
- 229960003459 allopurinol Drugs 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 229930014626 natural product Natural products 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000002000 scavenging effect Effects 0.000 description 5
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 238000005502 peroxidation Methods 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 238000004611 spectroscopical analysis Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000218691 Cupressaceae Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- QJYNZEYHSMRWBK-NIKIMHBISA-N 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose Chemical compound OC1=C(O)C(O)=CC(C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(O)C(O)=C(O)C=2)=C1 QJYNZEYHSMRWBK-NIKIMHBISA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- IGKWMHUOBKCUQU-USJZOSNVSA-N Aceritannin Natural products O[C@@H]1[C@@H](O)[C@H](COC(=O)c2cc(O)c(O)c(O)c2)OC[C@@H]1OC(=O)c3cc(O)c(O)c(O)c3 IGKWMHUOBKCUQU-USJZOSNVSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 244000059939 Eucalyptus gunnii Species 0.000 description 2
- 235000004504 Eucalyptus gunnii Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229910052956 cinnabar Inorganic materials 0.000 description 2
- 238000002983 circular dichroism Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- UDEWPOVQBGFNGE-UHFFFAOYSA-N propyl benzoate Chemical compound CCCOC(=O)C1=CC=CC=C1 UDEWPOVQBGFNGE-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-UHFFFAOYSA-N alpha-D-glucopyranose Natural products OCC1OC(O)C(O)C(O)C1O WQZGKKKJIJFFOK-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002390 cell membrane structure Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000010265 fast atom bombardment Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- LEXBBZCFWJNTGC-UHFFFAOYSA-N gallicin Natural products C1CC(=C)C(O)CCC(C)=CC2OC(=O)C(C)C21 LEXBBZCFWJNTGC-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229920001461 hydrolysable tannin Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 신나무(Acer ginnala) 잎으로부터 분리한 신규의 갈로탄닌(gallotannin) 화합물 및 이를 유효성분으로 포함하는 항산화용 조성물에 관한 것이다. 보다 상세하게는 신규로 분리된 갈로탄닌 화합물인 2,4-디-O-갈로일-1,5-안히드로-D-글루시톨(2,4-di-O-galloyl-1,5-anhydro-D-glucitol) 및 2,4,6-트리-O-갈로일-1,5-안히드로-D-글루시톨(2,4,6-tri-O-galloyl-1,5-anhydro-D-glucitol)과, 이들 화합물의 항산화제로서의 용도에 관한 것이다.
The present invention is a new tree ( Acer ginnala ) relates to a novel gallotannin compound isolated from leaves and an antioxidant composition comprising the same as an active ingredient. More specifically, 2,4-di- O -galloyl-1,5-anhydro-D-glycitol (2,4-di- O- galloyl-1,5-, which is a newly isolated gallotannin compound anhydro-D-glucitol) and 2,4,6-tri- O -galloyl-1,5-anhydro-D-glucitol (2,4,6-tri- O -galloyl-1,5-anhydro -D-glucitol) and the use of these compounds as antioxidants.
신나무(Acer ginnala)는 단풍나무과에 속하며 산기슭과 낮은 산에서 널리 자라며, 잎은 탄닌(tannin)의 원료로 쓰이며 민간에서는 설사멎이 약으로 쓰이고 있다. 신나무의 잎은 DPPH 라디칼(radical)을 강력하게 소거하는 항산화 활성과 함께 쉬겔라 플렉스네리(Shigella flexneri) 및 황색포도상구균(Pseudomonas aeruginosa)와 같은 그람음성균에 대한 항균활성을 갖는 것으로 보고되어 있고, 성분 연구로써 당을 모핵으로 하고 갈산(gallic acids)를 치환기로 갖는 갈로탄닌(gallotannin) 계열 화합물들이 다량 함유되어 있는 것으로 보고되어 있다. 신나무 잎에 다량 포함되어 있는 것으로 알려진 아세르탄닌(Acertannin)은 갈로탄닌(gallotannin)의 일종으로서, 1922년에 처음으로 그 존재가 확인되었고(Perkin, A.G. and Uyeda, Y. J. Chem. Soc. p66, 1922), 1980년 Bock에 의해 그 구조가 명확하게 밝혀졌다. 대한민국 공개특허 제1999-0030624호에는 신나무 잎으로부터 분리 정제한 항산화능을 갖는 갈리신(Gallicin) 화합물과 이 화합물의 분리 정제방법이 개시되어 있고, 대한민국 공개특허 제1999-025781호에는 신나무 잎에서 분리정제한 아세르탄닌(acertannin)계열 화합물과 이 화합물의 천연 항산화제로서의 용도에 관해 개시되어 있다. Acer ginnala is a member of the family Mapleaceae , which grows widely in the foothills and low mountains. Leaves are used as a source of tannin and diarrhea is used as a medicine in the private sector. It has been reported that the leaves of the new tree have antimicrobial activity against Gram-negative bacteria, such as Shigella flexneri and Pseudomonas aeruginosa , along with antioxidant activity that strongly eliminates DPPH radicals. Studies have reported high levels of gallotannin-based compounds with sugar as the nucleus and gallic acids as substituents. Acertannin, which is known to be contained in a large amount of the leaves of a new tree, is a type of gallotannin, first identified in 1922 (Perkin, AG and Uyeda, YJ Chem. Soc. P66, 1922). The structure was clarified by Bock in 1980. Korean Patent Laid-Open Publication No. 1999-0030624 discloses a Gallicin compound having an antioxidant activity, which is purified and purified from the leaves of a cypress, and a method for separating and purifying the compound, and Korean Patent Laid-Open Publication No. 1999-025781 discloses a separation from a cypress leaf. Purified acertannin-based compounds and their use as natural antioxidants are disclosed.
한편, 자유라디칼은 화학적으로 반응성이 매우 큰 화학물질로서, 인체 내에서는 여러 가지 원인 즉, 자외선, 방사선, 배기가스, 담배연기, 스트레스 등의 외부적 요인과 체내의 미토콘드리아 및 백혈구의 대사과정 에 의해서 생성되어, 다단계의 연쇄반응을 통하여 세포막의 구성성분인 지질의 과산화를 일으키게 된다. 자유라디칼은 대부분 활성 산소종(Reactive Oxygen Species, ROS)으로, 그 종류로는 수퍼옥사이드 라디칼(Super oxide radical), 과산화수소(H2O2), 하이드록시 라디칼(Hydroxy radical), 단일상태의 산소(Singlet oxygen) 등이 있다. 이들에 의해 일어나는 지질의 과산화는 라디칼, 과산화물, 알데히드(aldehyde) 및 에폭사이드(epoxide)의 다양한 활성 산소종을 발생시키고, DNA, RNA, 단백질, 세포막 및 세포 구조에 손상을 입힌다. 또한, 이러한 활성 산소종들은 암, 조직 손상, 노화, 피부 노화 등의 주원인으로 생각되고 있다(Black HS, Photochemphotobiol. 46(2):213(1987)). 예를 들어, 세포를 구성하는 막지질의 과산화는 세포막의 구조와 유동성 변화, 세포질 물질의 투과성 증가, 라이소좀 효소의 누출, 막효소와 운반 단백질의 불활성화, 지질과 단백질의 공유가교결합의 생성, 단백질 사슬 절단, DNA 손상, 돌연변이 등을 유발시키게 된다. 또한, 피부 구성 세포막의 과산화와 진피 구성 단백질들의 변형에 의해 피부 노화를 유발하는 것으로 알려져 있다. 종래에는 항산화제로서 BHT(2,6-di-tertibutyl-4-methylphenol), BHA (2-tert0butyl-4-methoxyphenol), PG(3,4,5-terhydroxy benzoic acid propyl ester) 등의 물질이 많이 사용되었다. 그러나, 식생활과 생활수준의 향상에 따라 이러한 합성 항산화제에 대해 소비자들이 거부감을 일으키는 등의 단점이 있다. 특히, 그 중에서도 종래에 가장 널리 이용되고 있는 합성 항산화제인 BHT는 50 ㎎/㎏/day 이상 섭취시 암이 유발된다는 보고가 있다.
Free radicals, on the other hand, are chemically highly reactive chemicals, which are caused by various causes in the human body: external factors such as ultraviolet rays, radiation, exhaust gases, tobacco smoke, stress, and metabolism of mitochondria and white blood cells in the body. It is produced through a multi-step chain reaction to cause peroxidation of lipids, which are components of cell membranes. Most of the free radicals are reactive oxygen species (ROS), which include super oxide radicals, hydrogen peroxide (H 2 O 2 ), hydroxy radicals, and single-phase oxygen ( Singlet oxygen). The peroxidation of lipids caused by them generates various reactive oxygen species of radicals, peroxides, aldehydes and epoxides and damages DNA, RNA, proteins, cell membranes and cellular structures. In addition, these reactive oxygen species are considered to be the main cause of cancer, tissue damage, aging, skin aging (Black HS, Photochemphotobiol. 46 (2): 213 (1987)). For example, the peroxidation of the membrane lipids that make up the cell may be caused by changes in cell membrane structure and fluidity, increased cellular permeability, leakage of lysosomal enzymes, inactivation of membrane enzymes and transport proteins, generation of covalent crosslinking of lipids and proteins, It causes protein chain breakage, DNA damage, and mutations. In addition, it is known to cause skin aging by peroxidation of skin cell membranes and modification of dermal constituent proteins. Conventionally, many antioxidants such as BHT (2,6-di-tertibutyl-4-methylphenol), BHA (2-tert0butyl-4-methoxyphenol), PG (3,4,5-terhydroxy benzoic acid propyl ester), etc. Was used. However, there are drawbacks such as consumers' rejection of such synthetic antioxidants as the diet and living standards improve. In particular, BHT, a synthetic antioxidant most widely used in the past, has been reported to cause cancer when ingested at 50 mg / kg / day or more.
본 명세서 전체에 걸쳐 다수의 논문 및 특허문헌이 참조되고 그 인용이 표시되어 있다. 인용된 논문 및 특허문헌의 개시 내용은 그 전체로서 본 명세서에 참조로 삽입되어 본 발명이 속하는 기술 분야의 수준 및 본 발명의 내용이 보다 명확하게 설명된다.
Numerous papers and patent documents are referenced and cited throughout this specification. The disclosures of the cited papers and patent documents are incorporated herein by reference in their entirety to better understand the state of the art to which the present invention pertains and the content of the present invention.
본 발명자들은 천연물로부터 항산화 활성을 갖는 화합물을 발굴하기 위해 예의 연구 노력하였다. 그 결과, 신나무(Acer ginnala) 잎 추출물로부터 신규의 갈로탄닌(gallotannin) 화합물을 분리해내고, 이 화합물이 강력한 DPPH 라디칼 소거활성 및 수퍼옥사이드(superoxide) 라디칼 소거활성을 나타내어 항산화 활성이 매우 우수함을 실험적으로 확인함으로써 본 발명을 완성하였다. The present inventors made diligent research efforts to find compounds having antioxidant activity from natural products. As a result, a novel gallotannin compound was isolated from the Acer ginnala leaf extract, and the compound showed strong DPPH radical scavenging activity and superoxide radical scavenging activity, and thus the antioxidant activity was very excellent. The present invention was completed by confirming with.
따라서, 본 발명의 목적은 신규 갈로탄닌 화합물을 제공하는 것에 있다. Accordingly, an object of the present invention is to provide a novel gallotannin compound.
또한, 본 발명의 다른 목적은 상기 신규 갈로탄닌 화합물을 유효성분으로 포함하는 항산화용 조성물을 제공하는 것에 있다.
In addition, another object of the present invention to provide an antioxidant composition comprising the novel gallotannin compound as an active ingredient.
본 발명의 목적 및 장점은 하기의 발명의 상세한 설명, 청구의 범위 및 도면에 의해 보다 명확하게 된다.
The objects and advantages of the present invention will become more apparent from the following detailed description of the invention, claims and drawings.
본 발명의 일 양태에 따르면, 본 발명은 하기 화학식 1 또는 화학식 2로 표시되는 신규의 갈로탄닌 화합물을 제공한다. According to one aspect of the present invention, the present invention provides a novel gallotannin compound represented by the following general formula (1) or (2).
본 발명의 다른 일 양태에 따르면, 본 발명은 상기 화학식 1 또는 화학식 2로 표시되는 신규의 갈로탄닌 화합물을 유효성분으로 포함하는 항산화용 조성물을 제공한다. According to another aspect of the present invention, the present invention provides a composition for antioxidant comprising a novel gallotannin compound represented by Formula 1 or Formula 2 as an active ingredient.
본 발명자들은 천연물로부터 항산화 활성을 갖는 화합물을 발굴하기 위해 예의 연구 노력하였다. 그 결과, 신나무(Acer ginnala) 잎 추출물로부터 신규의 갈로탄닌(gallotannin) 화합물을 분리해내고, 이 화합물이 강력한 DPPH 라디칼 소거활성 및 수퍼옥사이드(superoxide) 라디칼 소거활성을 나타내어 항산화 활성이 매우 우수함을 실험적으로 확인함으로써 본 발명을 완성하였다. The present inventors made diligent research efforts to find compounds having antioxidant activity from natural products. As a result, a novel gallotannin compound was isolated from the Acer ginnala leaf extract, and the compound showed strong DPPH radical scavenging activity and superoxide radical scavenging activity, and thus the antioxidant activity was very excellent. The present invention was completed by confirming with.
본 명세서에서 용어 "갈로탄닌(gallotannin)"은 가수분해 가능한 탄닌 화합물의 한 종류로서, 폴리페놀 모노머인 갈산(gallic acid)이 하나 또는 둘이상으로 글루코오스와 같은 폴리올 탄수화물의 히드록실기에 에스테르 결합을 통해 결합한 폴리머성 화합물을 지칭한다. 가장 대표적인 갈로탄닌 화합물로는 펜타갈로일글루코오스(β-1,2,3,4,6-pentagalloyl-O-D-glucopyranose)를 들 수 있다. As used herein, the term “gallotannin” refers to a hydrolyzable tannin compound, in which one or more polyphenol monomers, such as gallic acid, form an ester bond to the hydroxyl group of a polyol carbohydrate such as glucose. Refers to a polymeric compound bound through. The most representative gallotannin compound is pentagalloyl glucose (β-1,2,3,4,6-pentagalloyl- O- D-glucopyranose).
본 발명의 상기 화학식 1로 표시되는 화합물은 2,4-디-O-갈로일-1,5-안히드로-D-글루시톨(2,4-di-O-galloyl-1,5-anhydro-D-glucitol)이고, 상기 화학식 2로 표시되는 화합물은 2,4,6-트리-O-갈로일-1,5-안히드로-D-글루시톨(2,4,6-tri-O-galloyl-1,5-anhydro-D-glucitol)으로서, 현재까지 보고된 바 없는 신규의 갈로탄닌 화합물이다. Compound represented by the formula (1) of the present invention is 2,4-di- O -galloyl-1,5-anhydro-D-glucitol (2,4-di- O -galloyl-1,5-anhydro -D-glucitol, and the compound represented by the formula (2) is 2,4,6-tri- O -galloyl-1,5-anhydro-D-glucitol (2,4,6-tri- O -galloyl-1,5-anhydro-D-glucitol), a novel gallotannin compound that has not been reported to date.
본 발명에서 상기 화학식 1 또는 2로 표시되는 신규 갈로탄닌 화합물은 천연물, 예를 들어, 신나무(Acer ginnala) 잎 추출물로부터 분리 정제된 것뿐만 아니라, 화학적으로 합성된 것도 추출물로부터 분리 정제된 것과 동일한 항산화 활성을 갖는다는 것은 당업자에게 자명하다. In the present invention, the novel gallotannin compound represented by Chemical Formula 1 or 2 is not only purified from natural products, for example, Acer ginnala leaf extract, but also chemically synthesized from the extract. It is apparent to those skilled in the art that it has activity.
본 발명에서 신나무 잎 추출물은 천연물로부터 추출물을 추출하는 당업계에 공지된 통상적인 방법에 따라, 즉, 통상적인 온도, 압력의 조건 하에서 통상적인 용매를 사용하여 분리할 수 있다. 본 발명의 신나무 잎 추출물을 추출하기 위한 추출 용매로는 추출공정에서 일반적으로 사용할 수 있는 용매를 사용할 수 있는데, 물, 탄소수 1-4개의 무수 또는 함수 저급 알코올(메탄올, 에탄올, 프로판올, 부탄올), 아세톤, 에틸아세테이트, 부틸아세테이트, 디클로로메탄, 클로로포름, 헥산 및 1,3-부틸렌 글리콜로 구성된 군으로부터 선택되는 용매를 사용하여 추출되는 것이 바람직하다. According to the conventional method known in the art for extracting an extract from natural products, the nectar leaf extract in the present invention may be separated using a conventional solvent under conditions of conventional temperature and pressure. As an extraction solvent for extracting the leaves of the young tree leaf of the present invention, a solvent which can be generally used in the extraction process may be used. It is preferred to extract using a solvent selected from the group consisting of acetone, ethyl acetate, butyl acetate, dichloromethane, chloroform, hexane and 1,3-butylene glycol.
본 발명의 갈로탄닌 화합물은 천연물 추출물부터 단일 화합물을 분리 및 정제하는 통상적인 방법에 의해 얻을 수 있다. 예컨대, 실리카겔 또는 셀라이트(celite)겔 컬럼을 이용한 여과(filtration), 액체 컬럼 크로마토그래피를 이용한 크기배제(size-exclusion) 크로마토그래피, 이온교환(ion-exchange) 크로마토그래피, 분배 크로마토그래피, 친화(affinity) 크로마토그래피 또는 이들 크로마토그래피의 조합을 들 수 있으나, 이에 한정되는 것은 아니다. 천연물 추출물로부터 분리된 단일 화합물은 당업계에 공지된 통상적인 분석 방법을 통해 동정할 수 있으며, 예컨대, MALDI-TOF MS (Matrix-Assisted Laser Desorption Ionization-Time Of Flight Mass Spectroscopy), EI MS (Electron Ionization Mass Spectroscopy), CI (Chemical Ionization Mass Spectroscopy), FABI (Fast Atom Bombardment Ionization), ESI-MS (Electrospray Ionization Mass Spectrometry)와 같은 질량분석법과, 적외선 분광법(IR Sectrum), 핵자기공명법(NMR, Nuclear Magnetic Resonance), CD (Circular Dichroism) 등을 들 수 있으나, 이에 한정되는 것은 아니다. The gallotannin compound of the present invention can be obtained by a conventional method of separating and purifying a single compound from a natural product extract. For example, filtration using silica gel or celite gel column, size-exclusion chromatography using ion column chromatography, ion-exchange chromatography, partition chromatography, affinity ( affinity chromatography or a combination of these chromatography, but is not limited thereto. Single compounds isolated from natural extracts can be identified through conventional analytical methods known in the art, such as, for example, Matrix-Assisted Laser Desorption Ionization-Time Of Flight Mass Spectroscopy (MALDI-TOF MS), Electron Ionization (EI MS). Mass spectroscopy (CI), chemical ion mass mass spectroscopy (CI), fast atom bombardment ion (FABI), electrospray ion mass spectrometry (ESI-MS), infrared spectroscopy (IR Sectrum), nuclear magnetic resonance (NMR) Magnetic Resonance), CD (Circular Dichroism) and the like, but is not limited thereto.
본 발명의 신규 갈로탄닌 화합물은 하기 본 발명의 구체적인 일 실시예에 의해 입증되는 바와 같이, 강력한 DPPH 라디칼 소거활성 및 수퍼옥사이드(superoxide) 라디칼 소거활성을 나타내어 항산화 활성이 매우 뛰어나다. 따라서, 상기 신규 갈로탄닌 화합물은 항산화 용도의 조성물의 유효성분으로 사용될 수 있으며, 구체적으로 항산화 활성을 갖는 화장품학적 조성물 또는 기능성 식품 조성물의 유효성분으로 사용될 수 있다. The novel gallotannin compound of the present invention exhibits strong DPPH radical scavenging activity and superoxide radical scavenging activity, as demonstrated by one specific embodiment of the present invention, which is very excellent in antioxidant activity. Therefore, the novel gallotannin compound may be used as an active ingredient of an antioxidant composition, and in particular, may be used as an active ingredient of a cosmetic composition or a functional food composition having antioxidant activity.
본 발명의 항산화용 조성물은 항산화용 화장품학적 조성물의 형태로 제조될 수 있다. 본 발명의 화장품학적 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 로션, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다. The antioxidant composition of the present invention may be prepared in the form of a cosmetic composition for antioxidant. The cosmetic composition of the present invention may be prepared into any of the formulations conventionally produced in the art, and may be prepared, for example, as a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, But are not limited to, cleansing, oils, powder foundations, emulsion foundations, wax foundations and sprays. More specifically, it may be prepared in the form of a flexible lotion, nutrition lotion, lotion, nutrition cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray or powder.
본 발명의 제형이 페이스트, 크림, 로션, 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다. When the formulation of the present invention is a paste, cream, lotion, or gel, the carrier component is animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide. This can be used.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다. In the case where the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. Especially, in the case of a spray, a mixture of chlorofluorohydrocarbons, propane / Propane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다. When the formulation of the present invention is a solution or an emulsion, a solvent, a dissolving agent or an emulsifying agent is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다. In the case where the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.
본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다. When the formulation of the present invention is an interfacial active agent-containing cleansing, the carrier component may include aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives, or ethoxylated glycerol fatty acid esters.
본 발명의 화장품학적 조성물에 포함되는 성분은 유효 성분과 담체 성분 이외에, 화장품학적 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제를 포함할 수 있다. Ingredients included in the cosmetic composition of the present invention, in addition to the active ingredient and the carrier component, include ingredients conventionally used in cosmetic compositions, for example, such as antioxidants, stabilizers, solubilizers, vitamins, pigments and flavorings Adjuvants may be included.
본 발명의 항산화용 조성물은 항산화용 기능성 식품 조성물의 형태로 제조될 수 있다. 본 발명의 기능성 식품 조성물은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 향미제 또는 천연 탄수화물을 추가 성분으로서 포함시킬 수 있다. 예를 들어, 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등); 디사카라이드(예컨대, 말토스, 수크로오스 등); 올리고당; 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등); 및 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)을 포함한다. 향미제로서 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등) 및 합성 향미제(예컨대, 사카린, 아스파르탐 등)을 이용할 수 있다. The antioxidant composition of the present invention may be prepared in the form of a functional food composition for antioxidant. The functional food composition of the present invention includes components that are ordinarily added during the manufacture of food, and includes, for example, proteins, carbohydrates, fats, nutrients, and seasonings. For example, when prepared with a drink, flavoring agents or natural carbohydrates may be included as additional ingredients in addition to the active ingredient. For example, natural carbohydrates include monosaccharides (eg, glucose, fructose, etc.); Disaccharides (eg maltose, sucrose, etc.); oligosaccharide; Polysaccharides (eg, dextrins, cyclodextrins, etc.); And sugar alcohols (eg, xylitol, sorbitol, erythritol, and the like). As the flavoring agent, natural flavoring agents (e.g., taumartin, stevia extract, etc.) and synthetic flavoring agents (e.g., saccharin, aspartame, etc.) can be used.
상술한 본 발명의 특징과 이점을 요약하면 다음과 같다: A summary of the features and advantages of the present invention described above is as follows:
(ⅰ)본 발명은 신나무 잎으로부터 분리된 신규 갈로탄닌 화합물을 제공한다.(Iii) The present invention provides a novel gallotanine compound isolated from the leaves of the new tree.
(ⅱ)본 발명의 신규 갈로탄닌 화합물은 강력한 항산화 활성을 가지므로, 항산화활성이 필요한 화장품, 기능성 식품 등의 활성성분으로 유용하게 사용될 수 있다.
(Ii) Since the novel gallotannin compound of the present invention has a strong antioxidant activity, it can be usefully used as an active ingredient in cosmetics, functional foods and the like which need antioxidant activity.
본 발명은 신규의 갈로탄닌 화합물 2,4-디-O-갈로일-1,5-안히드로-D-글루시톨과 2,4,6-트리-O-갈로일-1,5-안히드로-D-글루시톨에 관한 것이다. 본 발명의 갈로탄닌 화합물은 강력한 DPPH 라디칼 소거활성 및 수퍼옥사이드(superoxide) 라디칼 소거활성을 나타내어 항산화 활성이 뛰어나, 천연의 항산화제로서, 성인병의 예방용 의약품, 기능성 화장품, 건강기능식품의 원료물질로 사용될 수 있다.
The present invention provides a novel gallotannin compound 2,4-di-O-galloyl-1,5-anhydro-D-glucitol and 2,4,6-tri-O-galloyl-1,5-an It relates to hydro-D-glucitol. The gallotannin compound of the present invention exhibits strong DPPH radical scavenging activity and superoxide radical scavenging activity and is excellent in antioxidant activity. As a natural antioxidant, it is a raw material for the prevention of adult diseases, functional cosmetics, and health functional foods. Can be used.
도 1은 신나무 잎 추출물의 DHHP 소거 활성을 측정한 결과이다.
도 2은 본 발명의 신규 갈로탄닌 화합물 2,4-디-O-갈로일-1,5-안히드로-D-글루시톨과 2,4,6-트리-O-갈로일-1,5-안히드로-D-글루시톨의 DHHP 소거 활성을 측정한 결과이다.
도 3은 신나무 잎 추출물의 수퍼옥사이드 소거 활성을 측정한 결과이다.
도 4는 본 발명의 신규 갈로탄닌 화합물 2,4-디-O-갈로일-1,5-안히드로-D-글루시톨과 2,4,6-트리-O-갈로일-1,5-안히드로-D-글루시톨의 수퍼옥사이드 소거 활성을 측정한 결과이다. 1 is a result of measuring the DHHP scavenging activity of the extract of the leaves of the new tree.
2 is a novel gallotannin compound 2,4-di-O-galloyl-1,5-anhydro-D-glucitol and 2,4,6-tri-O-galloyl-1,5 of the present invention. The result of measuring the DHHP scavenging activity of -anhydro-D-glucitol.
Figure 3 is the result of measuring the superoxide scavenging activity of the leaves of the new tree.
4 is a novel gallotannin compound 2,4-di-O-galloyl-1,5-anhydro-D-glucitol and 2,4,6-tri-O-galloyl-1,5 of the present invention. The result of measuring the superoxide scavenging activity of -anhydro-D-glucitol.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.
Hereinafter, the present invention will be described in more detail with reference to Examples. It is to be understood by those skilled in the art that these embodiments are only for describing the present invention in more detail and that the scope of the present invention is not limited by these embodiments in accordance with the gist of the present invention .
실시예Example
실시예Example 1: One: 신나무God Tree 잎 추출물 및 단일 화합물의 분리 Isolation of Leaf Extracts and Single Compounds
신나무 잎(2.0 kg)을 80% 메탄올로 실온에서 3회 추출하여 여과한 후 그 추출액을 감압 농축하여 추출물 674g을 얻었다. 추출물은 Sephadex LH-20 (2 kg, 10 X 80 cm) 레진(resin)에 40% 메탄올에서부터 메탄올의 함량을 10%씩 올려 100% 까지 농도를 높이는 이동상 조건으로 총 6개의 서브-분획(subfraction)으로 나누었다. 그 중 분획 4 (59.94g)와 분획 5 (21.73g)를 MCI-gel CHP20P (600g, 5 X 60 cm)과 ODS (600g, 5 X 60 cm) 레진에 물-메탄올 농도구배 시스템을 이용하여 수행한 결과, 단일화합물로서 각각 2,4-디-O-갈로일-1,5-안히드로글루시톨과, 2,4,6-트리-O-갈로일-1,5-안히드로글루시톨을 얻었다.
The leaves of the cypress (2.0 kg) were extracted three times with 80% methanol at room temperature, filtered, and the extract was concentrated under reduced pressure to obtain 674 g of the extract. The extract was made up of six subfractions in a Sephadex LH-20 (2 kg, 10 X 80 cm) resin with mobile phase conditions increasing concentrations from 40% methanol to 10% in methanol by up to 100%. Divided by. Fraction 4 (59.94g) and Fraction 5 (21.73g) were carried out using a water-methanol gradient system on MCI-gel CHP20P (600g, 5 X 60 cm) and ODS (600 g, 5 X 60 cm) resins. As a result, as a single compound, 2,4-di-O-galloyl-1,5-anhydroglucitol and 2,4,6-tri-O-galloyl-1,5-anhydroglusy, respectively Toll was obtained.
실시예 2: 분리한 단일 화합물의 구조 동정 Example 2 Structure Identification of Isolated Single Compound
(1) 2,4-디-O-갈로일-1,5-안히드로글루시톨의 구조 동정 (1) Identification of the structure of 2,4-di-O-galloyl-1,5-anhydroglucitol
분리한 본 발명의 2,4-디-O-갈로일-1,5-안히드로글루시톨 화합물의 분광학적 데이터는 다음과 같았다. Spectroscopic data of the isolated 2,4-di-O-galloyl-1,5-anhydroglucinitol compound of the present invention was as follows.
① 1H-NMR (600 MHz, DMSO-d 6 + D2O); δ 6.97 (4H, each s, 2X galloyl-2H), 4.80 (1H, t, J = 9.6 Hz, H-4), 4.79 (1H, m, H-2), 3.98 (1H, dd, J = 5.4, 11.1 Hz, H-1a), 3.80 (1H, t, J = 9.3 Hz, H-3), 3.46 (1H, m, H-5), 3.98 (1H, dd, J = 5.4, 11.1 Hz, H-1a), 3.38 (1H, dd, J = 1.8, 11.4 Hz, H-6a), 3.30 (1H, dd, J = 3.9, 11.4 Hz, H-6b), 3.30 (1H, t, J = 11.1 Hz, H-1b). ① 1 H-NMR (600 MHz, DMSO- d 6 + D 2 O); δ 6.97 (4H, each s, 2X galloyl-2H), 4.80 (1H, t, J = 9.6 Hz, H-4), 4.79 (1H, m, H-2), 3.98 (1H, dd, J = 5.4 , 11.1 Hz, H-1a), 3.80 (1H, t, J = 9.3 Hz, H-3), 3.46 (1H, m, H-5), 3.98 (1H, dd, J = 5.4, 11.1 Hz, H -1a), 3.38 (1H, dd, J = 1.8, 11.4 Hz, H-6a), 3.30 (1H, dd, J = 3.9, 11.4 Hz, H-6b), 3.30 (1H, t, J = 11.1 Hz , H-1b).
② 13C-NMR (150 MHz, DMSO-d 6 + D2O); δ 165.5~165.8 (C-7',7''), 145.8 (C-3',3'',5',5''), 138.8~138.9 (C-4',4''), 119.5~119.7 (C-1',1''), 109.2~109.3 (C-2',2'',6',6''), 79.9 (C-5), 73.0 (C-3), 72.3 (C-2), 72.0 (C-4), 66.5 (C-1), 61.2 (C-6). ② 13 C-NMR (150 MHz, DMSO- d 6 + D 2 O); δ 165.5 ~ 165.8 (C-7 ', 7``), 145.8 (C-3', 3 '', 5 ', 5''), 138.8 ~ 138.9 (C-4', 4 ''), 119.5 ~ 119.7 (C-1 ', 1''), 109.2-109.3 (C-2', 2 '', 6 ', 6''), 79.9 (C-5), 73.0 (C-3), 72.3 (C -2), 72.0 (C-4), 66.5 (C-1), 61.2 (C-6).
③ HRFAB-MS m/z; 467.0831 [M-H]- (calculated for C20H19O13, 467.0826) ③ HRFAB-MS m / z ; 467.0831 [M − H] − (calculated for C 20 H 19 O 13 , 467.0826)
상기의 분광학적 데이터에 기초하여 본 발명의 화합물은 하기 화학식 1로 표시되는 신규의 2,4-디-O-갈로일-1,5-안히드로글루시톨 화합물임을 확인하였다. Based on the spectroscopic data, it was confirmed that the compound of the present invention is a novel 2,4-di-O-galloyl-1,5-anhydroglucitol compound represented by the following Chemical Formula 1.
[화학식 1][Formula 1]
(2) 2,4,6-트리-O-갈로일-1,5-안히드로글루시톨의 구조동정 (2) Structural Identification of 2,4,6-Tri-O-galloyl-1,5-anhydroglucitol
분리한 본 발명의 2,4,6-트리-O-갈로일-1,5-안히드로글루시톨 화합물의 분광학적 데이터는 다음과 같았다. Spectroscopic data of the isolated 2,4,6-tri-O-galloyl-1,5-anhydroglucitol compound of the present invention were as follows.
① 1H-NMR(600 MHz, MeOH-d 4 + D2O); δ 7.09~7.11 (6H, each s, 3 X galloyl-2H), 5.22 (1H, t, J= 9.6 Hz, H-4), 5.02 (1H, m, H-2), 4.42, (1H, dd, J = 2.4, 12.0 Hz, H-6a), 4.21 (1H, dd, J= 4.8, 12.0 Hz, H-6b), 4.18 (1H, dd, J = 5.4, 11.1 Hz, H-1a), 4.03 (1H, t, J= 9.3 Hz, H-3), 3.85 (1H, m, H-5), 3.45 (1H, t, J =11.1 Hz, H-1b). ① 1 H-NMR (600 MHz, MeOH- d 4 + D 2 O); δ 7.09 ~ 7.11 (6H, each s, 3 X galloyl-2H), 5.22 (1H, t, J = 9.6 Hz, H-4), 5.02 (1H, m, H-2), 4.42, (1H, dd , J = 2.4, 12.0 Hz, H-6a), 4.21 (1H, dd, J = 4.8, 12.0 Hz, H-6b), 4.18 (1H, dd, J = 5.4, 11.1 Hz, H-1a), 4.03 (1H, t, J = 9.3 Hz, H-3), 3.85 (1H, m, H-5), 3.45 (1H, t, J = 11.1 Hz, H-1b).
② 13C-NMR (150 MHz, MeOH-d 4 + D2O); δ 161.1~161.7 (C-7',7'',7'''), 145.0~145.1 (C-3',3'',3''',5',5'',5'''), 138.5~138.7 (C-4',4'',4'''), 119.6~119.8 (C-1',1'',1'''), 108.9~109.0 (C-2',2'',2''',6',6'',6'''), 76.8 (C-5), 73.4 (C-3), 71.8 (C-2), 71.1 (C-4), 66.6 (C-1), 62.7 (C-6). ② 13 C-NMR (150 MHz, MeOH- d 4 + D 2 O); δ 161.1 ~ 161.7 (C-7 ', 7``, 7'''), 145.0 ~ 145.1 (C-3 ', 3'',3''', 5 ', 5'',5''') , 138.5 ~ 138.7 (C-4 ', 4'',4'''), 119.6 ~ 119.8 (C-1 ', 1'',1'''), 108.9 ~ 109.0 (C-2 ', 2'',2''', 6 ', 6'',6'''), 76.8 (C-5), 73.4 (C-3), 71.8 (C-2), 71.1 (C-4), 66.6 ( C-1), 62.7 (C-6).
③ HRFAB-MS m/z ; 619.0933 [M-H]- (calculated for C27H23O17, 619.0935) ③ HRFAB-MS m / z; 619.0933 [M − H] − (calculated for C 27 H 23 O 17 , 619.0935)
상기의 분광학적 데이터에 기초하여 본 발명의 화합물은 하기 화학식 2로 표시되는 신규의 2,4,6-트리-O-갈로일-1,5-안히드로글루시톨 화합물임을 확인하였다. [화학식 2] On the basis of the spectroscopic data, it was confirmed that the compound of the present invention is a novel 2,4,6-tri-O-galloyl-1,5-anhydroglucitol compound represented by the following Chemical Formula 2. [Formula 2]
실시예 3: 항산화 실험 Example 3: Antioxidant Experiment
(1) (One) DPPHDPPH 라디칼Radical 소거능Scatters (( radicalradical scavengingscavenging activityactivity ) 측정 ) Measure
DPPH(200 mM) 용액 180 ㎕에 각 농도별 샘플 20 ㎕을 첨가하여 30 분간 방치 후 518nm 에서 흡광도(O.D.)를 측정하였다. 각 샘플의 DPPH 라디칼 소거능은 [1-(sample O.D.- blank O.D.) / (control O.D. - blank O.D.)] X 100 식에 의해 산출하였다. 양성대조군으로는 비타민 C (Vitamin C)를 사용하였다.
20 μl of each sample was added to 180 μl of DPPH (200 mM) solution, and the absorbance (OD) was measured at 518 nm after standing for 30 minutes. DPPH radical scavenging ability of each sample was calculated by the formula [1- (sample OD-blank OD) / (control OD-blank OD)]
(2) 수퍼옥사이드(Superoxide) 라디칼 소거능 측정 (2) Determination of Superoxide Radical Scavenging Activity
수퍼옥사이드 라디칼의 소거능은 크산틴옥시다아제(xanthin oxidase)가 크산틴(xanthin)을 요산(uric acid)으로 산화시키는 과정에서 생성되는 수퍼옥사이드 음이온을 감소시키는 지를 측정함으로써 수행하였다. 포스페이트 완충액(Phospate buffer) (50 mM), EDTA (0.05 mM), NBT (1 mM), 하이포크산핀(hypoxanthine)(0.2 mM)을 첨가한 혼합물 160 ㎕에 각 농도별 샘플 20 ㎕을 넣고, 크산틴 옥시다아제(xanthine oxidase) (1.2 U/㎕) 20 ㎕를 첨가하여, 37℃에서 30 분간 방치한 후 590 nm에서 흡광도를 측정하였다. 각 샘플의 수퍼옥사이드 라디칼 소거능은 [1-(sample O.D.- blank O.D.) / (control O.D. - blank O.D.)] X 100 식에 의해 산출하였다. 양성 대조군으로는 알로푸리놀(allopurinol)을 사용하였다.
The scavenging ability of the superoxide radical was performed by measuring whether xanthin oxidase reduced the superoxide anion generated in the process of oxidizing xanthin to uric acid. 20 μl of the sample at each concentration was added to 160 μl of the mixture containing phosphate buffer (50 mM), EDTA (0.05 mM), NBT (1 mM), hypoxanthine (0.2 mM), and xanthine. 20 μl of xanthine oxidase (1.2 U / μl) was added thereto, and the absorbance was measured at 590 nm after standing at 37 ° C. for 30 minutes. The superoxide radical scavenging ability of each sample was calculated by the formula [1- (sample OD-blank OD) / (control OD-blank OD)]
(3) 실험결과 (3) Experiment result
① DPPH 라디칼 소거능 ① DPPH radical scavenging ability
신나무 잎 추출물의 DPPH 라디칼 소거능을 측정한 결과, 양성대조군인 비타민 C와 비교하여 대등한 수준의 DPPH 라디칼 소거능을 가지고 있음을 확인할 수 있었다(도 1 참조). 신나무 잎 추출물로부터 분리된 본 발명의 신규 갈로탄닌(gallotannin) 화합물의 DPPH 라디칼 소거능을 측정한 결과, 양성대조군인 비타민 C와 비교하여 더 우수한 DPPH 라디칼 소거능을 가짐을 확인하였다(도 2 참조).
As a result of measuring the DPPH radical scavenging activity of the extract of the leaves of the young tree, it was confirmed that it has a similar level of DPPH radical scavenging ability compared to the vitamin C which is a positive control group (see FIG. 1). As a result of measuring the DPPH radical scavenging ability of the novel gallotannin compound of the present invention isolated from the leaves of the Cider tree, it was confirmed that the DPPH radical scavenging ability was superior to that of the positive control vitamin C (see FIG. 2).
② 수퍼옥사이드 라디칼 소거능 ② Superoxide radical scavenging ability
신나무 잎 추출물의 수퍼옥사이드 라디칼 소거능을 측정한 결과, 양성대조군인 알로푸리놀(allopurinol)과 비교하여 대등한 수준의 수퍼옥사이드 라디칼 소거능을 가지고 있음을 확인할 수 있었다(도 3 참조). 신나무 잎 추출물로부터 분리된 본 발명의 신규 갈로탄닌(gallotannin) 화합물의 수퍼옥사이드 라디칼 소거능을 측정한 결과, 양성대조군인 알로푸리놀과 비교하여 낮은 농도에서는 더 우수한 수퍼옥사이드 라디칼 소거능을 가지고 있음을 확인할 수 있었다(도 4 참조). As a result of measuring the superoxide radical scavenging ability of the extract of the leaves of the tree, it was confirmed that the superoxide radical scavenging ability was comparable to that of the positive control group allopurinol (see FIG. 3). As a result of measuring the superoxide radical scavenging ability of the novel gallotannin compound of the present invention isolated from the leaves of Cider tree, it can be seen that it has a superior superoxide radical scavenging ability at low concentration compared to the positive control allopurinol. (See FIG. 4).
하기 표 1은 신나무 잎 추출물의 DPPH 라디칼 소거능과 수퍼옥사이드 라디칼 소거능의 IC50 값을 측정한 결과를 나타낸 표이다. Table 1 is a table showing the results of measuring the IC 50 value of DPPH radical scavenging activity and superoxide radical scavenging ability of the Cinnabar leaf extract.
하기 표 2은 신나무 잎 추출물의 DPPH 라디칼 소거능과 수퍼옥사이드 라디칼 소거능의 IC50 값을 측정한 결과를 나타낸 표이다. Table 2 is a table showing the results of measuring the IC 50 value of DPPH radical scavenging activity and superoxide radical scavenging activity of the Cinnabar leaf extract.
(μM)DPPH radical scavenging activity
(μM)
소거능 (μM) Superoxide radical
Scavenging power (μM)
이상으로 본 발명의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현 예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.
While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the same is by way of illustration and example only and is not to be construed as limiting the scope of the present invention. Thus, the substantial scope of the present invention will be defined by the appended claims and equivalents thereof.
Claims (4)
[화학식 1]
[화학식 2]
The novel gallotannin compound represented by the following general formula (1) or (2).
[Formula 1]
(2)
[화학식 1]
[화학식 2]
An antioxidant composition comprising a novel gallotannin compound represented by the following Formula 1 or Formula 2 as an active ingredient.
[Formula 1]
(2)
The composition of claim 2, wherein the composition is in the form of an antioxidant cosmetic composition.
The composition of claim 2, wherein the composition is in the form of an antioxidant functional food composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110001375A KR101261380B1 (en) | 2011-01-06 | 2011-01-06 | Novel Gallotannin Compound Isolated From Leaf of Acer ginnala and Antioxidative Composition Comprising the Same As Acitive Ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110001375A KR101261380B1 (en) | 2011-01-06 | 2011-01-06 | Novel Gallotannin Compound Isolated From Leaf of Acer ginnala and Antioxidative Composition Comprising the Same As Acitive Ingredient |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120079983A true KR20120079983A (en) | 2012-07-16 |
KR101261380B1 KR101261380B1 (en) | 2013-05-08 |
Family
ID=46712764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110001375A KR101261380B1 (en) | 2011-01-06 | 2011-01-06 | Novel Gallotannin Compound Isolated From Leaf of Acer ginnala and Antioxidative Composition Comprising the Same As Acitive Ingredient |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101261380B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014172888A (en) * | 2013-03-12 | 2014-09-22 | Kose Corp | Intracellular oxidative stress inhibiting agent containing extract from acer ginnala |
KR20150094979A (en) * | 2014-02-12 | 2015-08-20 | 남부대학교산학협력단 | Anti-Bacterial Composition Against Salmonella spp. Comprising Extract from Acer ginnala Max as Active Ingredient |
US20170029397A1 (en) * | 2014-04-04 | 2017-02-02 | Rhode Island Board Of Education, State Of Rhode Island & Providence Plantations | Methods for sking whitening using a gallotannin |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190110890A (en) | 2018-03-21 | 2019-10-01 | 원광대학교산학협력단 | Inhibitory effect of callotannin on colorectal metastasis |
-
2011
- 2011-01-06 KR KR1020110001375A patent/KR101261380B1/en active IP Right Grant
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014172888A (en) * | 2013-03-12 | 2014-09-22 | Kose Corp | Intracellular oxidative stress inhibiting agent containing extract from acer ginnala |
KR20150094979A (en) * | 2014-02-12 | 2015-08-20 | 남부대학교산학협력단 | Anti-Bacterial Composition Against Salmonella spp. Comprising Extract from Acer ginnala Max as Active Ingredient |
US20170029397A1 (en) * | 2014-04-04 | 2017-02-02 | Rhode Island Board Of Education, State Of Rhode Island & Providence Plantations | Methods for sking whitening using a gallotannin |
US10155738B2 (en) * | 2014-04-04 | 2018-12-18 | University Of Rhode Island | Methods for skin whitening using a gallotannin |
Also Published As
Publication number | Publication date |
---|---|
KR101261380B1 (en) | 2013-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101261380B1 (en) | Novel Gallotannin Compound Isolated From Leaf of Acer ginnala and Antioxidative Composition Comprising the Same As Acitive Ingredient | |
KR102298042B1 (en) | Composition for antioxidant and anti-inflammatory comprising extract of pepper seeds | |
KR101453609B1 (en) | Novel Hemiterpene Glucoside Compounds Isolated from the Leaves of Spiraea prunifolia and Anti-Oxidative and Anti-Inflammatory Use Thereof | |
JP4268896B2 (en) | Flavanone compound, method for producing the same, and antioxidant | |
KR101469886B1 (en) | Manufacturing method of Cosmetic composition | |
WO2022254867A1 (en) | Novel phenylpropanoid compound | |
KR101396059B1 (en) | Novel Sulfated Phenolic Compounds Isolated from the Leaves of Myrica rubra Sieb. et Zucc and Anti-Oxidative and Anti-Inflammatory Use Thereof | |
KR20200064384A (en) | Cosmetic composition of antioxidant, anti-inflammatory containing artemisia princeps pampanini | |
US7074907B2 (en) | Compound, process for producing the same and use thereof | |
KR20190079338A (en) | A cosmetic composition comprising fractions of extracts of flower of Forsythia koreana as an active ingredient | |
JP4344309B2 (en) | Antihyperglycemic agent | |
KR100363112B1 (en) | Novel Material Separated from Ecklonia cava, The Method for Extracting and Purifying the Same, And The Use Thereof for Antioxidants | |
KR101440677B1 (en) | Novel Hydrolysable Tannis Isolated from the Leaves of Cleyera japonica Thunberg and Anti-Oxidative Use Thereof | |
KR100363111B1 (en) | Novel Material Separated from Ecklonia cava, The Method for Extracting and Purifying the Same, And The Use Thereof for Antioxidants | |
KR101608882B1 (en) | Cosmetic Composition Comprising Golden Peanut Extracts | |
KR102565298B1 (en) | Extracts of plant Containing High-Content of Taxifolin and Method for Producing the same | |
KR102438389B1 (en) | Composition for preventing or improving skin wrinkle comprising stilbene derivative from Vitis vinifera root as effective component | |
KR100262383B1 (en) | Beta-glucogallin compound having antioxidant activity and preparation method thereof | |
KR20120135448A (en) | New compounds purified from the leaves of ilex rotunda and anti-oxidative effect thereof | |
KR101630439B1 (en) | New compounds purified from the leaves of alnus sibirica fisch. ex turcz and anti-oxidative composition comprising them | |
KR101117563B1 (en) | Composition Containing Extract from Litchi chinensis for Anti-oxidation | |
KR20190006258A (en) | Japanses cedar leaf extract having antioxidant activity and use thereof | |
KR101855208B1 (en) | Cosmetic composition for preventing near infrared ray containing extract of phseolus radiate | |
KR101888999B1 (en) | Cosmetic composition containing ultrasonicating extract of mahkota dewa | |
KR20110114369A (en) | Cosmetic composition comprising extraction of apple flower leaf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160325 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20170327 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20180406 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20190807 Year of fee payment: 7 |